Howard Jacob, PhD

Genomics and common human disease

Faculty Investigator

“Genomic medicine is a team sport,” says Howard Jacob, PhD.

As a faculty investigator and the executive vice president for genomic medicine at the HudsonAlpha Institute for Biotechnology, Jacob is leading a team that is finding ways to change people’s lives.

In his research, Jacob verifies that specific DNA changes cause disease, especially for undiagnosed conditions. And he wants to find a way to pinpoint those genetic conditions fast enough to benefit a patient.

“Science is inherently slow and methodical, which is great,” he says. “But not if you’re trying to help a sick patient.”

Then Jacob adds his research to work from other HudsonAlpha investigators, bringing genome sequencing, data analysis and basic research together to make a diagnosis possible. “My role is to integrate these researchers that are doing fabulous work independently and create space for them to not only do world class science individually but also contribute to a larger team,” Jacob says. “It’s one part participant, one part coach, one part motivator.”

Jacob received his PhD in pharmacology from the University of Iowa in 1989. He completed his postdoctoral work at Harvard, Stanford and MIT. Before joining HudsonAlpha in 2015, Jacob was the founding director of the Human and Molecular Genetics Center and a professor in the departments of physiology and pediatrics at the Medical College of Wisconsin (MCW) in Milwaukee for nearly 20 years.

At MCW, Jacob led a team that was the first in the world to successfully use DNA sequencing to identify and treat an unknown disease in a patient. That experienced saved the patient’s life and changed Jacob’s. “I always believed genomics was going to improve medicine,” he says. “But it went from being a dream to being a passion. I’m frustrated that we’re not helping more people today, when I know we could be changing lives. The good news is that we are going to be changing lives, and changing medicine, through genomics.”

Recent News

August 15, 2017
The All of Us Research Program Advisory Panel, a working group of the NIH Council of Councils, recently established the Genomics Working Group to help inform the program’s comprehensive genomics strategy. Howard Jacob, PhD, will...
August 1, 2017
HudsonAlpha’s Howard Jacob, PhD, will join the who’s who of the rare disease community as a guest speaker at the 2017 Global Genes Rare Patient Advocacy Summit September 14-15. The 2017 RARE Patient Advocacy Summit brin...
July 31, 2017
Nadiya Sosonkina, PhD, a postdoctoral fellow in the Jacob Lab at HudsonAlpha Institute for Biotechnology, has been selected as a fellow in the UAB-HudsonAlpha Genomic Medicine Training program. Sosonkina’s research focuses on th...
Load More


Color Skin